ليست عنوان مقالات لاتين Cardiac complications of secondary hyperparathyroidism in chronic hemodialysis patients Cardiomyopathy in infancy and postmortem di diagnosis of a fatty acid oxidation defect

<< مقالات لاتين >>

<< بر اساس عنوان >>

1

Cardiac complications of secondary hyperparathyroidism in chronic hemodialysis patients

2

Cardiac Complications of Thoracic Irradiation

3

Cardiac complications of vaccines

4

Cardiac complications with vertically transmitted HIV infection

5

Cardiac compression by a thymic cyst

6

Cardiac Compression Devices: Alternative Technology and Innovative Concept

7

Cardiac compression of a hepatic cyst in polycystic liver disease: A rare cause of hemodynamic instability

8

Cardiac compromise in a patient with Downʹs Syndrome: a lesson learnt

9

Cardiac Computed Tomographic Angiography: Whatʹs the Prognosis?

10

Cardiac computed tomography and radiation

11

Cardiac concomitants of performance monitoring: Context dependence and individual differences

12

Cardiac conduction abnormalities in endocarditis defined by the Duke criteria

13

Cardiac Conduction Disorders in Children with Community-Acquired Pneumonia

14

Cardiac conduction disturbances after an overdose of nefazodone and gabapentin

15

Cardiac Conduction Disturbances Seen After Transcatheter Device Closure of Muscular Ventricular Septal Defects With the Amplatzer Occluder

16

Cardiac conduction system involvement in sudden death of obese young people

17

Cardiac Consequences of Aldosterone Excess In Human Hypertension

18

Cardiac consequences of malnutrition—ancel keys revisited!

19

Cardiac contractility modulation by electric currents applied during the refractory period in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy

20

Cardiac Contractility Modulation Electrical Signals Improve Myocardial Gene Expression in Patients With Heart Failure Original Research Article

21

Cardiac Contraction Motion Correction in Gated Myocardial Perfusion SPECT Projection Domain

22

Cardiac contusion as a primary clinical entity

23

Cardiac contusion: Ending myocardial confusion in this capricious syndrome

24

Cardiac CT Angiography of a Membranous Ventricular Septal Aneurysm Short Title: Ventricular Septal Aneurysm

25

Cardiac CT in Mixed Type Atrial Septum Defects

26

Cardiac cycle-dependent changes in aortic area and distensibility are reduced in older patients with isolated diastolic heart failure and correlate with exercise intolerance

27

Cardiac cytoarchitecture and myofibril attachment during development and disease

28

Cardiac cytokine expression after myocardial infarction in rats

29

Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study

30

Cardiac death and stored electrograms in patients with third-generation implantable cardioverter-defibrillators

31

Cardiac death—current concepts

32

Cardiac Dedifferentiated Liposarcoma Requiring a Mitral Valve Replacement Complicated by Severe Paravalvular Leak: A Rare Case Report with Literature Review

33

Cardiac delayed enhancement distribution in extralysosomial glycogen storage disease

34

Cardiac Deletion of the Coxsackievirus-Adenovirus Receptor Abolishes Coxsackievirus B3 Infection and Prevents Myocarditis In Vivo

35

Cardiac Denervation After Radiofrequency Ablation of Supraventricular Tachycardias

36

Cardiac denervation in amyloid polyneuropathy

37

Cardiac depression scale: Validation of a new depression scale for cardiac patients

38

Cardiac Differentiation of Adipose Tissue-Derived Stem Cells Is Driven by BMP4 and bFGF but Counteracted by 5-Azacytidine and Valproic Acid

39

Cardiac differentiation of cardiosphere-derived cells in scaffolds mimicking morphology of the cardiac extracellular matrix

40

Cardiac dimension and function in patients with childhood onset growth hormone deficiency, before and after growth hormone retreatment in adult age

41

Cardiac disease after chest irradiation for Hodgkinʹs disease: incidence in 108 patients with long follow-up

42

Cardiac disease and risk of sudden death in the young: the burden of the phenomenon

43

Cardiac disease construction on the borderland

44

Cardiac Disease Evaluation and Management Among Kidney and Liver Transplantation Candidates: A Scientific Statement From the American Heart Association and the American College of Cardiology Foundation

45

Cardiac disease in pregnancy—A.I.I.M.S. experience

46

Cardiac disease, anxiety, and sexual functioning

47

Cardiac Disorder in an Iranian Child With Hepatitis A Virus

48

Cardiac disorders and mode of action of the Egyptian scorpion venom Androctonus bicolor on isolated toad’s heart

49

Cardiac drug-psychotropic drug update

50

Cardiac dysautonomia in patients with superior vena cava syndrome due to compression by lung cancer

51

Cardiac dysfunction after burns

52

Cardiac dysfunction and abnormal responses to hemodynamic stress in mice lacking s100a1 protein

53

Cardiac Dysfunction and Serum Ferritin Level as Early Prognostic Markers in Children with Sepsis: A Cross-sectional Study

54

Cardiac Dysfunction in a Child with Severe Multisystem Inflammatory Syndrome

55

Cardiac dysfunction in cirrhosis

56

Cardiac dysfunction in human immunodeficiency virus (HIV) infected patients in India

57

Cardiac dysfunction in portal hypertension among patients with cirrhosis and non-cirrhotic portal fibrosis

58

Cardiac dysfunction is attenuated by ginkgolide B via reducing oxidative stress and fibrosis in diabetic rats

59

Cardiac dysfunction with Becker muscular dystrophy

60

Cardiac dysrhythmia in COVID-19 patients; occurrence and risk factors: a retrospective cohort study

61

Cardiac Dysrhythmias and Neurological Dysregulation: Manifestations of Profound Hypomagnesemia

62

Cardiac Dyssynchrony in Congestive Heart Failure and Atrial Fibrillation: Integrating Regularization and Resynchronization

63

Cardiac dystrophin abnormalities in Becker muscular dystrophy assessed by endomyocardial biopsy

64

Cardiac echinococcosis causing coronary artery disease

65

Cardiac Echinococcosis: Surgical Treatment and Results in 10 Cases

66

Cardiac effects of acute myelitis

67

Cardiac Effects of Antiretroviral Therapy in HIV-Negative Infants Born to HIV-Positive Mothers: NHLBI CHAART-1 (National Heart, Lung, and Blood Institute Cardiovascular Status of HAART Therapy in HIV-Exposed Infants and Children Cohort Study)

68

Cardiac Effects of Calcium Antagonists in Systemic Hypertension

69

Cardiac effects of exercise rehabilitation in hemodialysis patients

70

Cardiac effects of l-thyroxine administration in borderline hypothyroidism

71

Cardiac electrophysiologic effects of norepinephrine in human beings, ,

72

Cardiac Electrophysiological Consequences of Neuromuscular Incapacitating Device Discharges Original Research Article

73

Cardiac electrophysiological effects of ETA & ETB receptor stimulation in isolated working rabbit hearts

74

Cardiac Electrophysiology Studies and Ablations for Treatment of Supraventricular Arrhythmias — An Initial Experience from Karachi

75

Cardiac electrophysiology: keeping in rhythm

76

Cardiac Ellis–van Creveld syndrome

77

Cardiac encasement by metastatic myxoid liposarcoma

78

Cardiac energy metabolism alterations in angiotensin II induced hypertrophy

79

Cardiac energy metabolism at several stages of adriamycin-induced heart failure in rats

80

Cardiac Energy Metabolism Homeostasis: Role of Cytosolic Calcium

81

Cardiac energy metabolism in patients with chest pain and normal coronary angiograms

82

Cardiac Entrapment During Minimally Invasive Aortic Valve Replacement

83

Cardiac enzyme (troponin levels) elevation in cardiac myxomas: Is it real?

84

Cardiac enzyme elevations after cardiac surgery: The cardiologistʹs perspective

85

Cardiac enzyme elevations after percutaneous coronary intervention: myonecrosis, the coronary microcirculation and mortality

86

Cardiac enzyme in emergency medicine

87

Cardiac enzymes and autotransfusion of shed mediastinal blood after myocardial revascularization

88

Cardiac epithelioid hemangioendothelioma with 8-year follow-up

89

CARDIAC EVALUATION OF PATIENTS WITH ISCHEMIC STROKE

90

Cardiac Event Rates After Acute Myocardial Infarction in Patients Treated With Verapamil and Trandolapril Versus Trandolapril Alone

91

Cardiac events in patients with negative maximal versus negative submaximal dobutamine echocardiograms undergoing noncardiac surgery: Importance of resting wall motion abnormalities Original Research Article

92

Cardiac Excrescences of Unusual Origin

93

Cardiac Expression and Subcellular Localization of the p38 Mitogen-activated Protein Kinase Member, Stress-activated Protein Kinase-3 (SAPK3)

94

Cardiac expression of glucocorticoid receptor α in mice

95

Cardiac expression of ID1 and ID3 is stimulated by chronic ischemia

96

Cardiac Expression of Placental Growth Factor Predicts the Improvement of Chronic Phase Left Ventricular Function in Patients With Acute Myocardial Infarction Original Research Article

97

Cardiac Expression of Sarcolipin Calpain After Immobilization Stress in Young Old Female Rats, Role of Alpha Beta Adrenoceptor Blockers

98

Cardiac extrinsic neuropathy: Lesions of the mediastinal paraganglia in chronic chagasic cardiomyopathy

99

Cardiac factors affecting the success of vardenafil in erectile dysfunction

100

Cardiac fatigue and oxygen kinetics after prolonged exercise

101

Cardiac Fibroblasts: Form and Function

102

Cardiac Fibroelastoma versus Thrombus: Echocardiographic Evidence Can Be Misleading

103

Cardiac Fibroma

104

Cardiac Fibroma in a Neonate Presenting With Dyspnea and Tachycardia: A Very Rare Case

105

Cardiac fibroma in an infant: single ventricle palliation as a bridge to heart transplantation

106

Cardiac fibrosis and down regulation of GLUT4 in experimental diabetic cardiomyopathy are ameliorated by chronic exposures to intermittent altitude

107

Cardiac Fibrosis in Human Transplanted Hearts Is Mainly Driven by Cells of Intracardiac Origin

108

Cardiac fibrosis occurs early and involves endothelin and AT-1 receptors in hypertension due to endogenous angiotensin II

109

Cardiac Findings After Enzyme Replacement Therapy for Mucopolysaccharidosis Type I

110

Cardiac Findings in Congenital Nephrotic Syndrome

111

Cardiac flow component analysis

112

Cardiac function and heart failure

113

Cardiac Function and Heart Failure Review Article

114

Cardiac Function and Heart Failure Review Article

115

Cardiac Function and Position More Than 5 Years After Pneumonectomy

116

Cardiac function at rest in hypothyroidism evaluated by equilibrium radionuclide angiography

117

Cardiac Function Before and After Surgery for Pectus Excavatum

118

Cardiac Function Before and After Surgery for Pectus Excavatum

119

Cardiac function during mild hypothermia in human-sized pigs: Increased inotropy at the cost of diastolic dysfunction

120

Cardiac function estimation from MRI using a heart model and data assimilation: Advances and difficulties

121

Cardiac Function in Brain Death, Usage of Advanced Hemodynamic Monitoring

122

Cardiac function in smokers and nonsmokers: The CARDI study

123

Cardiac Function Modeling in Patients With Acute Myocardial Infarction Based on Type D Personality Considering the Mediating Role of Health-Promoting Lifestyle

124

Cardiac glycosides could protect brain cells from stroke

125

Cardiac hemangioendothelioma

126

Cardiac Hemangioma

127

Cardiac Hemangioma: A Benign Tumor with Different Morphological Appearances

128

Cardiac hemochromatosis

129

Cardiac Hemodynamic and Coronary Angiographic Characteristics of Patients Being Evaluated for Liver Transplantation

130

Cardiac Hemodynamics in Men Versus Women During Acute ST-Segment Elevation Myocardial Infarction

131

Cardiac Hemosiderosis in Transfusion DependentThalassemia: A Mini-Review

132

Cardiac Hepatopathy Versus End-Stage Liver Disease: Two Different Entities

133

Cardiac homeobox gene NKX2-5 mutations and congenital heart disease: Associations with atrial septal defect and hypoplastic left heart syndrome

134

Cardiac hormone: predictive of prognosis

135

Cardiac hydatid cyst located in the interventricular septum

136

Cardiac Hydatid Cyst without Liver Involvement: A Case Re-port

137

Cardiac Hydatid Cyst: A Case Report

138

Cardiac Hydatid Cyst: A Case Report

139

Cardiac hydatid cyst: A rare presentation of echinococcal infection

140

Cardiac Hydatid Cyst: An Unusual Cause of Chest Pain

141

Cardiac hydatid cysts

142

Cardiac hydatid cysts with intracavitary expansion

143

Cardiac hydatid cysts: Reply

144

Cardiac hydatidosis : A rare infection of the heart with hydatid cyst of Echinococcus granulosus can produced anaemia

145

Cardiac Hypertrophy Alters Expression of Na+,K+-ATPase Subunit Isoforms at mRNA and Protein Levels in Rat Myocardium

146

Cardiac Hypertrophy Due to Hydrocortisone Treatment in a Preterm Infant: A Case Report

147

Cardiac hypertrophy in chronically anemic fetal sheep: Increased vascularization is associated with increased myocardial expression of vascular endothelial growth factor and hypoxia-inducible factor 1

148

Cardiac hypertrophy in deceased users of anabolic androgenic steroids: an investigation of autopsy findings

149

Cardiac hypertrophy in hypertension: relation to 24-h blood pressure profile and arterial stiffness

150

Cardiac hypertrophy in the Dahl rat is associated with increased tyrosine phosphorylation of several cytosolic proteins, including a 120 kDa protein

151

Cardiac hypertrophy in the prague hypertensive rat (PHR) is associated with enhanced JNK2 but not ERK tissue activity

152

Cardiac IK1 underlies early action potential shortening during hypoxia in the mouse heart

153

Cardiac imaging

154

Cardiac imaging

155

Cardiac Imaging in FIP1L1-PDGFRA

156

Cardiac Imaging in Patients With Chronic Obstructive Pulmonary Disease and Chronic Heart Failure

157

Cardiac imaging in the evaluation of mitral annulus caseous calcification

158

Cardiac Imaging Integration in 2009 and Beyond

159

Cardiac Imaging Integration in 2009 and Beyond: Cardiovascular magnetic resonance

160

Cardiac Imaging Secrets: Neil J. Weissman and Gabriel A. Adelmann, Eds., Philadelphia, PA: Hanley and Belfus, 2003, 350 pages, 100 illustrations, US$36.95.

161

Cardiac imaging using optison

162

Cardiac imaging—the requisites, 2nd edition. Stephen Wilmot Miller (Ed). Philadelphia, PA: Mosby, imprint of Elsevier Science, 2004, 464 pages, 894 illustrations (US$99.00).

163

Cardiac immunocyte-derived (AL) amyloidosis: An endomyocardial biopsy study in 11 patients

164

Cardiac implications of Lyme disease, diagnosis and therapeutic approach

165

Cardiac implications of the morning surge in blood pressure in elderly hypertensive patients: Relation to arising time

166

Cardiac index quantification by Doppler ultrasound in patients without left ventricular outflow tract abnormalities

167

Cardiac infections: focus on molecular diagnosis

168

Cardiac Infertility in Persian Medicine: Avicenna’s View

169

Cardiac inflammation contributes to right ventricular dysfunction following experimental pulmonary embolism in rats

170

Cardiac inhibitory response to alpha stimulation is blunted in young patients with essential hypertension.

171

Cardiac Injuries: A Review of Multidetector Computed Tomography Findings

172

Cardiac injury by a nail gun

173

Cardiac Injury by Activated Leukocytes: Effect of Cyclooxygenase and Lipoxygenase Inhibition Evaluated by Electron Microscopical Morphometry

174

Cardiac instrument development in a low-literacy population: The revised Chest Discomfort Diary

175

Cardiac Integrins: The Ties That Bind

176

Cardiac Intensivism: A View From a Fellow-in-Training

177

Cardiac intracavitary metastasis of a malignant solitary fibrous tumor: case report and review of the literature on sarcomas with left intracavitary extension

178

Cardiac involvement according to echocardiographic findings in severe coronavirus disease 2019

179

Cardiac Involvement and Echocardiographic Characteristics in Rheumatoid Arthritis

180

Cardiac Involvement and Subsequent Death due to Extranodal NK/T Cell Cutaneous T-Cell Lymphoma: An Autopsy Case and Brief Review of the Literature

181

Cardiac involvement in a case of acute lymphoblastic leukemia

182

Cardiac Involvement in a Fetus With Vein of Galen Aneurysmal Malformation, Diagnosis, and Treatment: A Case Report

183

Cardiac Involvement in a Patient with Eosinophilia and Inversion of Chromosome 16(p13q22): A Case of Chronic Eosinophilic Leukemia or AML-M4EO?

184

Cardiac Involvement in Adults With m.3243A>G MELAS Gene Mutation

185

Cardiac involvement in childhood polyarteritis nodosa

186

Cardiac involvement in Dengue Haemorrhagic Fever

187

Cardiac Involvement in Lysosomal Diseases

188

Cardiac Involvement in Mild Cystic Fibrosis Lung Involvement Assessed by Tissue‐Doppler Echocardiography

189

Cardiac Involvement in Non-Hodgkin Lymphoma, an Incidental Large Atrial Mass: A Case Report

190

Cardiac Involvement in Non-Hodgkin Lymphoma, an Incidental Large Atrial Mass: A Case Report

191

Cardiac Involvement in Systemic Lupus Erythematosus: Echocardiographic Evaluation

192

Cardiac involvement in systemic rheumatic diseases: An update

193

Cardiac Involvement in the Churg-Strauss Syndrome

194

Cardiac Involvement in Von Hippel-Lindau Disease

195

Cardiac involvement in Wegener granulomatosis diagnosed at autopsy

196

Cardiac involvement is a constant finding in acute Chagasʹ disease: a clinical, parasitological and histopathological study

197

Cardiac involvement over 10 years in myotonic and Becker muscular dystrophy and mitochondrial disorder

198

Cardiac Involvement with Diffuse Large B Cell Lymphoma

199

Cardiac Involvements in Patients with Celiac Disease by Doppler Tissue Echocardiography Compared to Conventional Echocardiography

200

Cardiac Iodine-123 Metaiodobenzylguanidine Imaging Predicts Sudden Cardiac Death Independently of Left Ventricular Ejection Fraction in Patients With Chronic Heart Failure and Left Ventricular Systolic Dysfunction: Results From a Comparative Study With Si

201

Cardiac ion channel expression and regulation: the role of innervation

202

Cardiac ion channels and antihistamines: possible mechanisms of cardiotoxicity

203

Cardiac ion channels and channelopathies

204

Cardiac ischemia/reperfusion, aging, and redox-dependent alterations in mitochondrial function

205

Cardiac ischemic preconditioning improves lung preservation in valve replacement operations

206

Cardiac isoform of alpha-2 macroglobulin—A new biomarker for myocardial infarcted diabetic patients

207

Cardiac issues related to trastuzumab

208

Cardiac KATP channels in health and disease

209

Cardiac Lipoma: An Uncharacteristically Large Intra-Atrial Mass Causing Symptoms

210

Cardiac Luxation to Facilitate Off-Pump Bilateral Lung Transplantation

211

Cardiac Lymphoma Following Mitral Valve Replacement

212

Cardiac Magnetic Resonance and the Need for Routine Cardiac Catheterization in Single Ventricle Patients Prior to Fontan: A Comparison of 3 Groups: Pre-Fontan CMR Versus Cath Evaluation

213

Cardiac Magnetic Resonance Detection of Myocardial Scarring in Hypertrophic Cardiomyopathy: Correlation With Histopathology and Prevalence of Ventricular Tachycardia

214

Cardiac magnetic resonance documentation of a double atrial septal defect before and after percutaneous closure with an Amplatzer septal occluder

215

Cardiac Magnetic Resonance Evaluation of the Impact of Interventricular and Intraventricular Dyssynchrony on Cardiac Ventricular Systolic and Diastolic Function in Patients With Isolated Left Bundle Branch Block

216

Cardiac Magnetic Resonance Findings in Congenitally Absent Pericardium

217

Cardiac Magnetic Resonance for Diagnosis of Neuroendocrine Tumor Metastases to the Right and Left Ventricles with Carcinoid Heart Disease

218

Cardiac Magnetic Resonance for Risk Stratification of Patients With Frequent Premature Ventricular Contractions

219

Cardiac magnetic resonance imaging and core cardiology training II (COCATS-2): Can we get there from here?

220

Cardiac Magnetic Resonance Imaging and Coronary Computed Tomography Angiography in the Diagnosis of Anomalous Coronary Artery

221

Cardiac Magnetic Resonance Imaging and the Assessment of Ebstein Anomaly in Adults

222

Cardiac Magnetic Resonance Imaging and the WATCHMAN Device

223

Cardiac Magnetic Resonance Imaging and Transesophageal Echocardiography in Patients With Transcatheter Closure of Patent Foramen Ovale Original Research Article

224

Cardiac Magnetic Resonance Imaging Correlates of Exercise Capacity in Patients With Surgically Repaired Tetralogy of Fallot

225

Cardiac Magnetic Resonance Imaging Findings and the Risk of Cardiovascular Events in Patients With Recent Myocardial Infarction or Suspected or Known Coronary Artery Disease: A Systematic Review of Prognostic Studies

226

Cardiac Magnetic Resonance Imaging Findings in a Patient with Ebstein’s Anomaly and Left Ventricular Dysfunction

227

Cardiac magnetic resonance imaging findings in a patient with noncompaction of ventricular myocardium

228

Cardiac Magnetic Resonance Imaging for Accurate Diagnosis of Aortic Arch Anomalies in Patients with 22q11.2 Deletion

229

Cardiac Magnetic Resonance Imaging for Diagnosis of Cardiac Sarcoidosis: A Meta-Analysis

230

Cardiac Magnetic Resonance Imaging Identification of Myocardial Fibrosis: The Need for Standardization and Therapies

231

Cardiac magnetic resonance imaging in arrhythmogenic right ventricular cardiomyopathy: correlation to the QRS dispersion

232

Cardiac magnetic resonance imaging in small animal models of human heart failure

233

Cardiac magnetic resonance imaging in the diagnosis of myocarditis mimicking myocardial infarction

234

Cardiac Magnetic Resonance Imaging in the Evaluation of the Late Effects of Anthracyclines Among Long-Term Survivors of Childhood Cancer

235

Cardiac magnetic resonance imaging of eosinophilic endomyocardial disease

236

Cardiac magnetic resonance imaging of systemic amyloidosis patients with normal left ventricular ejection fraction: An initial study

237

Cardiac Magnetic Resonance Imaging Signal Characteristics of Cardiac Tumors in Children

238

Cardiac Magnetic Resonance Imaging Study for Quantification of Infarct Size Comparing Directly Serial Versus Single Time-Point Measurements of Cardiac Troponin T Original Research Article

239

Cardiac magnetic resonance imaging training

240

Cardiac magnetic resonance imaging using radial k-space sampling and self-calibrated partial parallel reconstruction

241

Cardiac magnetic resonance imaging: A teaching atlas with emphasizing current clinical indications

242

Cardiac magnetic resonance imaging: infarct size is an independent predictor of mortality in patients with coronary artery disease

243

Cardiac magnetic resonance in outpatients in Germany—indications, complications and protocol suggestions from a high-volume center

244

Cardiac Magnetic Resonance Measurements of Area at Risk and Infarct Size in Ischemic Syndromes

245

Cardiac Magnetic Resonance Predicts Outcome in Patients With Premature Ventricular Complexes of Left Bundle Branch Block Morphology

246

Cardiac magnetic resonance training: How we can get there from here

247

Cardiac Magnetic Resonance With Edema Imaging Identifies Myocardium at Risk and Predicts Worse Outcome in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome

248

Cardiac Magnetic Resonance-Directed Intervention in Non–ST-Segment Elevation Acute Coronary Syndrome

249

Cardiac Malformations in Fetuses of Gestational and Pre Gestational Diabetic Mothers

250

Cardiac malignant lymphoma with atrial arrhythmias

251

Cardiac management by pediatricians versus pediatric cardiologists in an inpatient academic center

252

Cardiac Manifestation of Mucocutaneous Lymph Node Syndrome (Kawasaki Disease)

253

Cardiac manifestations in antiphospholipid syndrome

254

Cardiac Manifestations in COVID-19 Patients: A Focus on the Pediatric Population

255

Cardiac Manifestations in Iranian Patients with Behçet’s Disease

256

Cardiac manifestations of Anderson–Fabry disease in heterozygous females

257

Cardiac Manifestations of Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 Infection

258

Cardiac marker testing: Where should we focus?

259

Cardiac markers and their point-of-care testing for diagnosis of acute myocardial infarction

260

Cardiac Markers in the Early Diagnosis and Management of Patients with Acute Coronary Syndrome

261

Cardiac markers of acute coronary syndromes: is there a case for point-of-care testing?

262

Cardiac Markers of Pre-Clinical Disease in Adolescents With the Metabolic Syndrome: The Strong Heart Study

263

Cardiac Markers: Centralized or Decentralized Testing?

264

Cardiac mass of the right atrium: an incidental finding

265

Cardiac mass-to-maximum power output: A novel index to assess left ventricular efficiency during exercise stress echocardiography

266

Cardiac mast cell- and chymase-mediated matrix metalloproteinase activity and left ventricular remodeling in mitral regurgitation in the dog

267

Cardiac Mast Cells: Implications for Heart Failure

268

Cardiac material markers from tagged MR images

269

Cardiac matrix metalloproteinase activation in patients undergoing coronary artery bypass grafting

270

Cardiac Medical Therapy Following Coronary Artery Bypass Graft Surgery

271

Cardiac medical therapy in patients after undergoing coronary artery bypass graft surgery: A review of randomized controlled trials Review Article

272

Cardiac Medical Therapy Post-Coronary Bypass Grafting

273

274

Cardiac Memory versus Likelihood of Ischemic Heart Disease in Hypertensive Patients with Ventricular Repolarization Abnormalities after Repetitive Uniform Ventricular Extrasystoles

275

Cardiac metabolism and function in type 2 diabetic (db/db) mice — Effect of PPARα agonist treatment

276

Cardiac metaiodobenzylguanidine uptake in patients with moderate chronic heart failure: relationship with peak oxygen uptake and prognosis

277

Cardiac Metal Contents After Infusions of Manganese An Experimental Evaluation in the Isolated Rat Heart

278

Cardiac Metastases of Malignant Melanoma

279

Cardiac metastasis after squamous cell carcinoma of the oral cavity: Case report

280

Cardiac Metastasis from a Renal Cell Carcinoma without Contiguous Vena Caval Involvement

281

Cardiac metastasis from a urothelial cell carcinoma: a commented case report

282

Cardiac metastasis mimicking acute STelevation myocardial infarction

283

Cardiac metastasis of tongue cancer may cause sudden death

284

Cardiac Metastatic Melanoma Investigated by Magnetic Resonance Imaging

285

Cardiac microvascular changes in DOCA-salt hypertensive rats: effect of endothelin ETA receptor antagonism

286

Cardiac Misconceptions and Patients Point of View about Explanation of Medical Diagnosis and the Therapeutic Regimen

287

Cardiac modifications occurring in the ascitic rat with biliary cirrhosis are nitric oxide related

288

Cardiac modulation of startle: Effects on eye blink and higher cognitive processing

289

Cardiac molecular markers of programmed cell death are activated in end-stage heart failure patients supported by left ventricular assist device

290

Cardiac monitoring after phenytoin overdose

291

Cardiac Monitoring Of Children With Household Electrical Injuries, ,

292

Cardiac morphogenetic defects and conduction abnormalities in mice homozygously deficient for connexin40 and heterozygously deficient for connexin45

293

Cardiac Morphology and Function in Senescent Rats: Gender-Related Differences

294

Cardiac Morphology and Left Ventricular Function in Normotensive Morbidly Obese Patients With and Without Congestive Heart Failure, and Effect of Weight Loss

295

Cardiac motion recovery using an incompressible B-solid model

296

Cardiac MRI in a Patient with Amyloidosis

297

Cardiac MRI in a Patient with Coincident Left Ventricular Non-Compaction and Hypertrophic Cardiomyopathy

298

Cardiac MRI in a Patient with Coincident Left Ventricular Non-Compaction and Hypertrophic Cardiomyopathy

299

Cardiac MRI in a Patient with Myocarditis

300

Cardiac MRI of ischemic heart disease at 3 T: potential and challenges

301

Cardiac multidetector-row computed tomography in patients with unstable angina

302

Cardiac muscle tissue engineering

303

Cardiac myocyte cytokinesis: The contractile ring is the thing

304

Cardiac myocyte nuclear size and ploidy status decrease after mechanical support

305

Cardiac myocyte proliferation requires activation of protein kinase C-epsilon

306

Cardiac myocytes derived from Nkx2.5-GFP knock-in murine embryonic stem cell: Electrophysiological differentiation and coupling with native cardiac myocytes

307

Cardiac myocytes of hearts from patients with end-stage dilated cardiomyopathy do not contain Borrelia burgdorferi DNA

308

Cardiac myofibroblasts: a novel source of vascular endothelial growth factor (VEGF) and its receptors Flt-1 and KDR

309

Cardiac Myofilament Protein Function is Altered During Sepsis

310

Cardiac myofilaments: mechanics and regulation

311

Cardiac myosin binding protein-C modulates actomyosin binding and kinetics in the in vitro motility assay

312

Cardiac myosin heavy chain isoenzymes and self ventricular defibrillation

313

Cardiac myosin phosphatase

314

Cardiac Myosin-Binding Protein C (MyBP-C): Identification of Protein Kinase A and Protein Kinase C Phosphorylation Sites

315

Cardiac Myxoma Removal and Coronary Artery Bypass Grafting in a MiddleAged Woman: A Case Report

316

Cardiac Myxoma with Glandular Component

317

Cardiac Myxoma, a Rare but Most Common Encountered Cardiac Tumor: A Single Center Experience

318

Cardiac Myxoma: 40 Years’ Experience in 63 Patients

319

Cardiac myxoma: a cytogenetic study of two cases

320

Cardiac myxoma: clinical experiences with twenty-five patients in Korea

321

Cardiac myxomas: Clinical and echocardiographic profile

322

Cardiac myxosarcoma: A case report

323

Cardiac NA,K-ATPase during hypertension: Regulatory role of nitric oxide

324

Cardiac Na/Ca Exchange Function in Rabbit, Mouse and Man: Whatʹs the Difference?

325

Cardiac Na+–H+Exchanger During Postnatal Development in the Rat: Changes in mRNA Expression and Sarcolemmal Activity

326

Cardiac Natriuretic Peptides: Gaining Further Insights Into Structure–Function Relationships

327

Cardiac NGF and GDNF expression during Trypanosoma cruzi infection in rats

328

Cardiac nitric oxide production due to angiotensin-converting enzyme inhibition decreases beta-adrenergic myocardial contractility in patients with dilated cardiomyopathy

329

Cardiac nitric oxide synthases are elevated in dietary copper deficiency

330

Cardiac nociceptors innervated by vagal afferents in rats

331

Cardiac Noradrenaline Release Accelerates Adenosine Formation in the Ischemic Rat Heart: Role of Neuronal Noradrenaline Carrier and Adrenergic Receptors

332

Cardiac nuclear medicine studies

333

Cardiac observations late after operative transmyocardial laser “revascularization”

334

Cardiac operation for a patient with autoimmune hemolytic anemia with warm-reactive antibodies

335

Cardiac operations during pregnancy: review of factors influencing fetal outcome

336

Cardiac Operations in Children With Marfan’s Syndrome: Indications and Results

337

Cardiac operations in octogenarians: perioperative risk factors for death and impaired autonomy

338

Cardiac Operations in Patients 80 Years Old and Older

339

Cardiac Operations in Patients 90 Years of Age and Older

340

Cardiac operations in patients aged 70 years and over: Mortality, length of stay, and hospital charge

341

Cardiac Operations in Patients With Cirrhosis

342

Cardiac Operations in Solid-Organ Transplant Recipients

343

Cardiac operations in the elderly: who is at risk?

344

Cardiac Origins of the Postural Orthostatic Tachycardia Syndrome

345

Cardiac outcome in patients with subarachnoid hemorrhage and electrocardiographic abnormalities: Zaroff JG, Rordorf GA, Newell JB, et al Neurosurgery 44:34–40 January 1999

346

Cardiac Outcomes in Coronary Patients With Submaximum Dobutamine Stress Echocardiography

347

Cardiac Outcomes in Young Adult Survivors of the Arterial Switch Operation for Transposition of the Great Arteries

348

Cardiac Outcomes With Submaximal Normal Stress Echocardiography: A Meta-Analysis

349

Cardiac Output Augmentation During Hypoxemia Improves Cerebral Metabolism After Hypothermic Cardiopulmonary Bypass

350

Cardiac output in single-lead VDD pacing versus rate-matched VVIR pacing

351

Cardiac output response to dynamic exercise after atrial switch repair for transposition of the great arteries

352

Cardiac Output Responses During Exercise in Volume-Expanded Heart Transplant Recipients

353

Cardiac overexpression of alcohol dehydrogenase exacerbates chronic ethanol ingestion-induced myocardial dysfunction and hypertrophy: Role of insulin signaling and ER stress

354

Cardiac overexpression of the α1A-adrenergic receptor limits post-infarct ventricular remodeling and dysfunction, and improves survival

355

Cardiac oxidative stress and remodeling following infarction: role of NADPH oxidase

356

Cardiac oxygenation by extracorporeal membrane oxygenation in exteriorized fetal lambs, , ,

357

Cardiac pacemaker cell failure with preserved If, ICaL, and IKr: A lesson about pacemaker function learned from ischemia-induced bradycardia

358

Cardiac pacemaker dysfunction in children after thoracic drainage catheter manipulation

359

Cardiac Pacemaker Infection: Surgical Management With and Without Extracorporeal Circulation

360

Cardiac pacemaker lead extraction using conventional techniques:a single centre experience

361

Cardiac pacemaker: In vitro assessment at 1.5 T

362

Cardiac pacemakers: Evaluation and management of malfunctions

363

Cardiac pacemaking: If vs. Ca2+, is it really that simple?

364

365

366

Cardiac Pacing and Psychologic Disorders

367

Cardiac pacing in balloon aortic valvuloplasty

368

Cardiac pacing in premature infants and neonates: steroid eluting leads and automatic output adaptation

369

Cardiac pacing: atrial fibrillation may go unrecognised

370

Cardiac pacing: the state of the art

371

Cardiac Papillary Fibroelastoma

372

Cardiac papillary fibroelastoma

373

Cardiac papillary fibroelastoma

374

Cardiac papillary fibroelastoma as a reason of transient ischemic attack for a young patient

375

Cardiac papillary fibroelastoma in left ventricular apex

376

Cardiac papillary fibroelastoma manifested as a left ventricular cystic mass

377

Cardiac papillary fibroelastoma on the pulmonary valve: a rare cardiac tumor

378

Cardiac papillary fibroelastoma: a comprehensive analysis of 725 cases

379

Cardiac papillary fibroelastomas: Rationale for excision

380

Cardiac Paraganglioma Presenting With Acute Myocardial Infarction and Stroke

381

Cardiac Paraganglioma, Recent Advances in Clinicopathologic Features

382

Cardiac parasympathetic dysfunction related to depression in older adults with acute coronary syndromes

383

Cardiac Parasympathetic Reactivation in Elite Soccer Players During Different Types of Traditional High-Intensity Training Exercise Modes and Specific Tests: Interests and Limits

384

Cardiac Parasympathetic Reactivation in Elite Soccer Players During Different Types of Traditional High-Intensity Training Exercise Modes and Specific Tests: Interests and Limits

385

Cardiac pathologic findings reveal a high rate of sudden cardiac death of undetermined etiology in younger women

386

Cardiac pathological changes of Atlantic salmon (Salmo salar L.) affected with heart and skeletal muscle inflammation (HSMI)

387

Cardiac patients’ beliefs about their illness and treatment: A sequential exploratory mixed methods design

388

Cardiac patients’ perception about psychological risk factors on chest pain intensity and discomfort

389

Cardiac pentastomiasis and tuberculosis: The worm-eaten heart

390

Cardiac peptide stability, aprotinin and room temperature: importance for assessing cardiac function in clinical practice

391

Cardiac perforation after device closure of atrial septal defects with the Amplatzer septal occluder Original Research Article

392

Cardiac performance early after cardioversion from atrial fibrillation, , , , ,

393

CARDIAC PERFORMANCE IN END STAGE RENAL DISEASE DIABETIC PATIENTS WITH ARTERIOVENOUS FISTULA

394

Cardiac performance is reduced following high-fat diet

395

Cardiac Performance Measure Compliance in Outpatients: The American College of Cardiology and National Cardiovascular Data Registryʹs PINNACLE (Practice Innovation And Clinical Excellence) Program

396

Cardiac phenotypes in relaxin knockout mice: Importance of the gender

397

Cardiac pheochromocytoma

398

Cardiac pheochromocytoma: resection after diagnosis by 111-indium octreotide scan

399

Cardiac phosphorus-31 two-dimensional chemical shift imaging in patients with hereditary hemochromatosis

400

Cardiac Physical Diagnosis in the Digital Age: An Important but Increasingly Neglected Skill (from Stethoscopes to Microchips)

401

Cardiac plasmacytoma

402

Cardiac Positron Emission Tomography

403

Cardiac positron emission tomography and the role of adenosine pharmacologic stress

404

Cardiac Positron Emission Tomography as a Prognostic Indicator of Cardiac Sarcoidosis

405

Cardiac Positron Emission Tomography Enhances Prognostic Assessments of Patients With Suspected Cardiac Sarcoidosis

406

Cardiac positron emission tomography imaging with [11c]hydroxyephedrine, a specific tracer for sympathetic nerve endings, and its functional correlates in congestive heart failure

407

Cardiac Positron Emission Tomography/Computed Tomography Imaging of the Renin-Angiotensin System in Humans Holds Promise for Image-Guided Approach to Heart Failure Therapy

408

Cardiac potassium channel dysfunction in sudden infant death syndrome

409

Cardiac potassium currents and channels: Part II: Implications for clinical practice and therapy

410

Cardiac potassium currents and channels-Part I: Basic science aspects

411

Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: A report from the SHOCK trial registry Original Research Article

412

Cardiac Power Output during Dobutamine Stress Test in Horses

413

Cardiac power output predicts mortality across a broad spectrum of patients with acute cardiac disease

414

Cardiac problems related to burns and/or burn treatment

415

Cardiac procedure use following acute myocardial infarction among American Indians

416

Cardiac Procedures in Lung Transplant Recipients Do Not Increase Mortality in Selected Patients

417

Cardiac Procedures in Patients With a Body Mass Index Exceeding 45: Outcomes and Long-Term Results

418

Cardiac progenitor cells application in cardiovascular disease

419

Cardiac protection during acute myocardial infarction: Where do we stand in 2004? Review Article

420

Cardiac protection: Evolving role of angiotensin receptor blockers

421

Cardiac Pseudopyogenic Granuloma: A Type of Vascular Hyperplasia in the Transplanted Heart Mimicking Pyogenic Granuloma

422

Cardiac pulsations in patients with isolated right ventricular infarction

423

Cardiac Regeneration Review Article

424

Cardiac Rehab: Bridging the Transition from Hospital to Home

425

Cardiac rehabilitation

426

Cardiac rehabilitation after myocardial infarction in the community Original Research Article

427

Cardiac rehabilitation and depression

428

Cardiac Rehabilitation and Prevention of Cardiovascular Disease: A Role for Autonomic Cardiovascular Regulation

429

Cardiac rehabilitation and secondary prevention in Australia and New Zealand

430

Cardiac Rehabilitation and Secondary Prevention Program effect in Chronic Total Occlusion Percutaneous Coronary Intervention patients

431

Cardiac Rehabilitation and Survival in Older Coronary Patients

432

Cardiac rehabilitation and survival in patients with left ventricular systolic dysfunction

433

Cardiac Rehabilitation Following Myocardial Infarction

434

Cardiac Rehabilitation for Patients With Ventricular Assist Devices: An Offer to Improve Strong Collaborative Relationships

435

Cardiac rehabilitation I: review of psychosocial factors

436

Cardiac rehabilitation II: referral and participation

437

Cardiac Rehabilitation Improves the QRS Fragmentation in Patients With ST Elevatıon Myocardial Infarction

438

CARDIAC REHABILITATION IN PATIENTS WITH DIABETES MELLITUS

439

CARDIAC REHABILITATION IN PATIENTS WITH DIABETES MELLITUS

440

Cardiac rehabilitation in skilled nursing facilities: A missed opportunity

441

Cardiac rehabilitation in the elderly

442

Cardiac Rehabilitation Program with High Intensity Aerobic Exercise Can Reverse Diastolic Impairment in Patients Undergoing Coronary Artery Bypass Surgery

443

Cardiac rehabilitation services in England and Wales: a national survey

444

Cardiac rehabilitation using simultaneous voice and electrocardiographic transtelephonic monitoring

445

Cardiac Rehabilitation, Exercise Training, and Anxiety

446

Cardiac Rehabilitation, Exercise Training, and Psychosocial Risk Factors

447

Cardiac Rehabilitation, Exercise Training, and Psychosocial Risk Factors: Reply

448

Cardiac rehabilitation: A review of current developments

449

Cardiac rehabilitation: How can it be improved?

450

Cardiac Relapse of Acute Myeloid Leukemia afterAllogeneic Hematopoietic Stem Cell Transplantation

451

Cardiac Release and Kinetics of Endothelin After Severe Short-Lasting Myocardial Ischemi

452

Cardiac Release and Kinetics of Endothelin After Uncomplicated Percutaneous Transluminal Coronary Angioplasty

453

Cardiac remodeling after long term norepinephrine treatment in rats

454

Cardiac remodeling after long-term stimulation by antibodies against the α1-adrenergic receptor in rats

455

Cardiac remodeling and failure: From molecules to man (Part I)

456

Cardiac remodeling and failure: From molecules to man (Part II)

457

Cardiac remodeling and failure: From molecules to man (Part III)

458

Cardiac remodeling and the role of matrix metalloproteinases in chronic anthracycline cardiotoxicity

459

Cardiac remodeling in coronary artery disease

460

Cardiac remodeling precedes clinical hypertension in offspring of hypertensive parents. The Bergen Blood Pressure Study

461

Cardiac remodeling rather than disturbed myocardial energy metabolism is associated with cardiac dysfunction in diabetic rats

462

Cardiac remodeling: is 8 the heart’s lucky number?

463

Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling

464

Cardiac remodelling in the era of aggressive medical therapy: does it still exist?

465

Cardiac reoperation by Carpentier bicaval femoral venous cannula: GATA experience

466

Cardiac reoperation in the intensive care unit

467

Cardiac reoperations in octogenarians: analysis of outcomes

468

Cardiac Repair in Patients with Trisomy 18: Total or Palliative?

469

Cardiac repair using chitosan-hyaluronan/silk fibroin patches in a rat heart model with myocardial infarction

470

Cardiac repolarisation can be detected as an ordered spatial process on the body surface

471

Cardiac Repolarization Changes in the Children with Breath-Holding Spells

472

Cardiac repolarization is prolonged in CD4C/HIV transgenic mice

473

Cardiac repolarization: Current knowledge, critical gaps, and new approaches to drug development and patient management

474

Cardiac rescue with intra-aortic balloon counterpulsation in refractory shock due to acute meningococcemia

475

Cardiac response to prolonged strenuous exercise: A physiologic model for stunning myocardium

476

Cardiac responses of vagus nerve stimulation: Intraoperative bradycardia and subsequent chronic stimulation

477

Cardiac responses to long duration and high magnitude +Gz exposure in pilots: An observational study

478

Cardiac Rest and Reserve Function in Patients With Fontan Circulation Original Research Article

479

Cardiac Restriction Secondary to Massive Calcific Deposits in the Left Ventricular Cavity

480

Cardiac Resurrection After Bone-Marrow-Derived Mononuclear Cell Transplantation During Left Ventricular Assist Device Support

481

Cardiac resynchronisation – a new standard in heart failure therapy

482

Cardiac resynchronisation may reduce all-cause mortality: meta-analysis of preliminary COMPANION data with CONTAK-CD, InSync ICD, MIRACLE and MUSTIC

483

Cardiac Resynchronisation Therapy in Heart Failure

484

Cardiac Resynchronization and Quality of Life in Patients With Minimally Symptomatic Heart Failure

485

Cardiac resynchronization by pacing: an electrical treatment of heart failure

486

Cardiac Resynchronization Devices: The Food and Drug Administration’s Regulatory Considerations Review Article

487

Cardiac Resynchronization for Asymptomatic or Mildly Symptomatic Heart Failure: A Bridge Too Far?

488

Cardiac Resynchronization in Mildly Symptomatic Heart Failure and Asymptomatic Patients

489

Cardiac Resynchronization in Patients With Atrial Fibrillation: A Meta-Analysis of Prospective Cohort Studies Original Research Article

490

Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation: Effect of upgrading to biventricular pacing after chronic right ventricular pacing

491

Cardiac Resynchronization Therapy

492

Cardiac resynchronization therapy 101: If itʹs not late, pacing it early wonʹt help

493

Cardiac Resynchronization Therapy and Atrial Tachyarrhythmias: A Question Still Searching for an Answer

494

Cardiac resynchronization therapy can reverse abnormal myocardial strain distribution in patients with heart failure and left bundle branch block

495

Cardiac resynchronization therapy for an unusual cause of cardiomyopathy

496

Cardiac Resynchronization Therapy for Mitral Systolic Anterior Motion in a Child

497

Cardiac Resynchronization Therapy for the Failing Fontan Patient

498

Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias

499

Cardiac resynchronization therapy improves central sleep apnea and Cheyne-Stokes respiration in patients with chronic heart failure Original Research Article

500

Cardiac Resynchronization Therapy Improves Heart Rate Profile and Heart Rate Variability of Patients With Moderate to Severe Heart Failure Original Research Article

501

Cardiac Resynchronization Therapy in Asymptomatic or Mildly Symptomatic Heart Failure Patients in Relation to Etiology: Results From the REVERSE (REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction) Study

502

Cardiac resynchronization therapy in chronic heart failure: How to select the patient that will benefit?

503

Cardiac resynchronization therapy in congenital heart disease

504

Cardiac Resynchronization Therapy in Patients With a Narrow QRS Complex Original Research Article

505

Cardiac Resynchronization Therapy in Patients With End-Stage Inotrope-Dependent Class IV Heart Failure

506

Cardiac Resynchronization Therapy in Patients With Left Bundle Branch Block Versus Right Ventricular Pacing

507

Cardiac Resynchronization Therapy in Patients With Minimal Heart Failure: A Systematic Review and Meta-Analysis

508

Cardiac resynchronization therapy in patients with narrow QRS

509

Cardiac Resynchronization Therapy in Patients With Systolic Left Ventricular Dysfunction and Symptoms of Mild Heart Failure Secondary to Ischemic or Nonischemic Cardiomyopathy

510

Cardiac Resynchronization Therapy Is More Effective in Women Than in Men: The MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy) Trial

511

Cardiac Resynchronization Therapy May Avoid Dilated Rather Than Ischemic Cardiomyopathy Patients the Need for Primary Prevention Defibrillator Implantation

512

Cardiac Resynchronization Therapy Modifies the Neurohormonal Profile, Hemodynamic and Functional Capacity in Heart Failure Patients

513

Cardiac Resynchronization Therapy Optimization Using Trans Esophageal Doppler in Patients with Dilated Cardiomyopathy

514

Cardiac Resynchronization Therapy Reduces Left Atrial Volume and the Risk of Atrial Tachyarrhythmias in MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy)

515

Cardiac resynchronization therapy restores optimal atrioventricular mechanical timing in heart failure patients with ventricular conduction delay

516

Cardiac resynchronization therapy tailored by echocardiographic evaluation of ventricular asynchrony

517

Cardiac resynchronization therapy upregulates cardiac autonomic control

518

Cardiac resynchronization therapy, central sleep apnea, and Cheyne-Stokes respiration in chronic heart failure patients

519

Cardiac resynchronization therapy, central sleep apnea, and Cheyne-Stokes respiration in chronic heart failure patients: Reply

520

Cardiac resynchronization therapy: A novel adjunct to the treatment and prevention of systemic right ventricular failure Original Research Article

521

Cardiac resynchronization therapy: A regulatory perspective

522

Cardiac Resynchronization Therapy: Antiarrhythmic or Proarrhythmic?

523

Cardiac Resynchronization Therapy: Are Modern Myths Preventing Appropriate Use?

524

Cardiac resynchronization therapy: caveat medicus! Review Article

525

Cardiac Resynchronization Therapy: Location Matters

526

Cardiac Resynchronization Therapy: Part 1—Issues Before Device Implantation Review Article

527

Cardiac Resynchronization Therapy: Part 2—Issues During and After Device Implantation and Unresolved Questions Review Article

528

Cardiac Resynchronization Therapy: The More Pacing Sites, the Better the Outcome?

529

Cardiac resynchronization therapyhomogenizes myocardial glucosemetabolism and perfusion in dilatedcardiomyopathy and left bundle branch block

530

Cardiac Resynchronization With Sequential Biventricular Pacing for the Treatment of Moderate-to-Severe Heart Failure Original Research Article

531

Cardiac resynchronization: a cornerstone in the foundation of device therapy for heart failure

532

Cardiac retransplantation in children

533

Cardiac rhabdomyoma

534

Cardiac rhabdomyoma in an adult patient presenting with right ventricular outflow tract obstruction

535

Cardiac Rhabdomyoma In Familial Tuberous Sclerosis

536

Cardiac Rhabdomyomas and Congenital Hypothyroidism: A Coincidence or Hamartia

537

Cardiac Rhabdomyomas and Obstructive Left Heart Disease: Histologically but Not Functionally Benign

538

Cardiac rhythm and symptomatic arrhythmia in right atrial isomerism

539

Cardiac rhythm disturbances in a bactrian camel (Camelus bactrianus) during anaesthesia for oral surgery: a case report

540

Cardiac Rhythm Management Devices: When Regulatory Agencies “Over-Regulate”

541

Cardiac risk factors

542

Cardiac risk factors

543

Cardiac risk for vascular surgery

544

Cardiac Risk in Patients Aged >75 Years With Asymptomatic, Severe Aortic Stenosis Undergoing Noncardiac Surgery

545

Cardiac risk in pregnant women with rheumatic mitral stenosis

546

Cardiac risk management in severe mental illness

547

Cardiac risk of noncardiac surgery in patients with hypertrophic cardiomyopathy

548

Cardiac risk stratification

549

Cardiac Risk Stratification in Renal Transplantation Using a Form of Artificial Intelligence

550

Cardiac risk: Theme con variations

551

Cardiac rupture – experience-based cardiology

552

Cardiac Rupture After Catheter Ablation Procedure

553

Cardiac rupture and tamponade during ventriculography

554

Cardiac rupture associated with thrombolytic therapy: Impact of time to treatment in the late assessment of thrombolytic efficacy (LATE) study

555

Cardiac rupture complicating myocardial infarction

556

Cardiac rupture during contrast-enhanced dobutamine stress echocardiography

557

Cardiac rupture during exercise test in post-myocardial infarction patients: a case report and brief review of the literature

558

Cardiac Rupture During Vacuum-Assisted Closure Therapy

559

Cardiac rupture or pericardial effusion?

560

Cardiac Sarcoidosis

561

Cardiac Sarcoidosis

562

Cardiac Sarcoidosis Detected by Late Gadolinium Enhancement and Prevalence of Atrial Arrhythmias

563

Cardiac sarcoidosis evaluated with gadolinium-enhanced magnetic resonance and contrast-enhanced 64-slice computed tomography

564

Cardiac sarcoidosis presenting as Heerfordt’s syndrome

565

Cardiac Sarcoidosis: A Contemporary Concept of Forgotten Granulomatosis

566

Cardiac Sarcoplasmic Reticular Function in Rats with Chronic Heart Failure Following Myocardial Infarction

567

Cardiac Sca-1+ and side population cells in cardiac regeneration

568

Cardiac screening proposed for HIV-1-infected children

569

Cardiac sensitization: methodology and interpretation in risk assessment

570

Cardiac signal extraction in patients with Implantable Cardioverter Defibrillators

571

Cardiac Single-Photon Emission Computed Tomography Myocardial Perfusion Imaging: Finally Up to Speed?

572

Cardiac sources of embolic cerebral infarction in transesophageal echocardiography

573

CARDIAC SOURCES OF EMBOLISM IN IRANIAN STROKE PATIENTS

574

Cardiac specific haploinsufficiency of β-catenin attenuates cardiac hypertrophy from aortic constriction

575

Cardiac specific two-year mortality related to initial post-thrombolytic flow grade

576

Cardiac stabilizer for minimally invasive direct coronary artery bypass

577

Cardiac state diagnosis using adaptive neuro-fuzzy technique

578

Cardiac Steatosis and Left Ventricular Hypertrophy in Patients With Generalized Lipodystrophy as Determined by Magnetic Resonance Spectroscopy and Imaging

579

Cardiac Steatosis and Myocardial Dysfunction

580

Cardiac Stem Cell Transplantation

581

Cardiac stem cells and myocardial disease

582

Cardiac stem cells: paradigm shift or broken promise? A view from developmental biology Original Research Article

583

Cardiac stents: the next generation

584

Cardiac storage with University of Wisconsin solution and a nucleoside-transport blocker

585

Cardiac Strain between Normal Weight and Overweight Workers in Hot/Humid Weather in the Persian Gulf

586

Cardiac stress adaptation and hyperlipidemia: Role of matrix metalloproteinase-2

587

Cardiac Structural and Electrical Adaptation in Male Active Athletes. QT Interval Could it be the Clue to Sudden Cardiac Death?

588

Cardiac Structure and Exercise Blood Pressure in Urban and Rural Canadian Men of Icelandic Descent

589

Cardiac structure and function Review Article

590

Cardiac structure and function after short-term ethanol consumption in rats

591

Cardiac Structure and Function as Predictors of Mortality in Persons 85 Years of Age

592

Cardiac structure and function in fetuses of mothers infected with HIV: The prospective P2C2HIV multicenter study

593

Cardiac Structure and Function in Persons 85 Years of Age

594

Cardiac Structure and Function in Young and Senescent Mice Heterozygous for a Connexin43 Null Mutation

595

Cardiac sulfonylurea receptor short form-based channels confer a glibenclamide-insensitive KATP activity

596

Cardiac Surgeon Report Cards, Referral for Cardiac Surgery, and the Ethical Responsibilities of Cardiologists

597

Cardiac surgeons in England face publication of outcomes data

598

Cardiac surgery

599

Cardiac surgery and cold-reactive proteins

600

Cardiac surgery and the acute care nurse practitioner—“the perfect link”

601

Cardiac Surgery for Grown-Up Congenital Heart Patients: Survey of 307 Consecutive Operations from 1991 to 1994

602

Cardiac surgery for octogenarians: is it an informed decision?

603

Cardiac surgery in a fixed-reimbursement environment

604

Cardiac surgery in African Americans

605

Cardiac Surgery in Children With End-Stage Liver Disease Awaiting Liver Transplantation

606

Cardiac surgery in moderate to end-stage renal failure: analysis of risk factors

607

Cardiac surgery in nonagenarians: Pushing the boundary one further decade

608

Cardiac surgery in octogenarians with poor lung function

609

Cardiac surgery in octogenarians: can elderly patients benefit? quality of life after cardiac surgery

610

Cardiac surgery in octogenarians: have we gone too far or not far enough?

611

Cardiac surgery in octogenarians: The informed decision is not whether to have it, but rather when and where to have it

612

Cardiac surgery in patients infected with the human immunodeficiency virus

613

Cardiac Surgery in Patients on Dialysis: Decreased 30-Day Mortality, Unchanged Overall Survival

614

Cardiac Surgery in Patients With Body Mass Index of 50 or Greater

615

Cardiac surgery in patients with end-stage renal disease: 10-year experience

616

Cardiac Surgery in Patients With Liver Cirrhosis

617

Cardiac Surgery in Renal Transplant Recipients: Experience from Washington Hospital Center

618

Cardiac Surgery in Select Nonagenarians: Should We or Shouldn’t We?

619

Cardiac Surgery in the Adult, second edition: Edited by Lawrence H. Cohn, MD, and L. Henry Edmunds, MD, New York, McGraw-Hill Professional, 2003, 1573 pp, illustrated, $250.00, ISBN: 0-07139-1290

620

Cardiac surgery in the octogenarian: evaluation of risk, cost, and outcome

621

Cardiac surgery report cards: comprehensive review and statistical critique

622

Cardiac surgery report cards: making the grade

623

Cardiac surgery risk modeling for mortality: a review of current practice and suggestions for improvement

624

Cardiac Surgery Risk Models: A Position Article

625

Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia

626

Cardiac Surgery with Crystalloid Cardioplegia: Improved Functional Recovery Due to Molecular Adaptations in Adult Rat Hearts

627

Cardiac surgery: myocardial energy balance, antioxidant status and endothelial function after ischemia–reperfusion

628

Cardiac surgical conditions induced by β-blockade: Effect on myocardial fluid balance

629

Cardiac surgical implications of calcium dyshomeostasis in the heart

630

Cardiac sympathetic activity as measured by myocardial 123-I-metaiodobenzylguanidine uptake and heart rate variability in idiopathic dilated cardiomyopathy

631

Cardiac Sympathetic Denervation Assessed With 123-Iodine Metaiodobenzylguanidine Imaging Predicts Ventricular Arrhythmias in Implantable Cardioverter-Defibrillator Patients

632

Cardiac sympathetic denervation detected with dobutamine infusion in patients with Parkinsonʹs disease: Correlation with cardiac 123I-metaiodobenzylguanidine (MIBG) uptake – A follow-up report

633

Cardiac Sympathetic Denervation in Patients With Coronary Artery Disease Without Previous Myocardial Infarction

634

Cardiac sympathetic denervationmodulates the sympathoexcitatoryresponse to acute myocardial ischemia

635

Cardiac Sympathetic Dysfunction Correlates With Abnormal Myocardial Contractile Reserve in Dilated Cardiomyopathy Patients Original Research Article

636

Cardiac sympathetic innervation and control of potassium channel function

637

Cardiac sympathetic innervation in patients with idiopathic right ventricular outflow tract tachycardi

638

Cardiac Syndrome X and Endothelial Dysfunction: New Concepts in Prognosis and Treatment

639

Cardiac syndrome X versus metabolic syndrome X

640

Cardiac syndrome X: Clinical characteristics and left ventricular function: Long-term follow-up study

641

Cardiac T2* measurements in patients with iron overload: a comparison of imaging parameters and analysis techniques

642

Cardiac Tamponade After a Systemic–Pulmonary Shunt Complicated by Serous Leakage

643

Cardiac tamponade after removal of atrial intracardiac monitoring catheters in a pediatric patient: Case report

644

Cardiac tamponade as a complication of catheterization of the subclavian vein—prevention and principles of management

645

Cardiac tamponade as a life-threatening complication in antireflux surgery

646

Cardiac Tamponade as an Initial Manifestation of Cervical Cancer

647

Cardiac tamponade as initial presentation of Sheehanʹs Syndrome

648

Cardiac tamponade as manifestation of advanced thymic carcinoma

649

Cardiac Tamponade as the Initial Presentation of Acute MyeloidLeukemia: A Case Report with Review of the Literature

650

Cardiac tamponade as unusual presentation of underlying unrecognized cancer

651

Cardiac Tamponade by Hydatid Pericardial Cyst: A Rare Case Report

652

Cardiac tamponade caused by a leaking coronary saphenous vein graft aneurysm

653

Cardiac Tamponade Caused by Cutibacterium acnes: An Updated and Comprehensive Review of the Literature

654

Cardiac tamponade complicating trimodal therapy for malignant mesothelioma

655

Cardiac tamponade due to pneumopericardium

656

Cardiac tamponade due to spontaneous rupture of right coronary artery aneurysm

657

Cardiac tamponade during thoracic endovascular aortic repair

658

Cardiac tamponade following pacemaker implantation

659

Cardiac tamponade from central venous catheters

660

Cardiac Tamponade from Purulent Pericarditis due to Cutibacterium acnes

661

Cardiac tamponade in a neglected case of thyroid agenesis

662

Cardiac tamponade in a patient treated by sunitinib for metastatic renal cell carcinoma

663

Cardiac tamponade in acquired immunodeficiency syndrome

664

Cardiac tamponade in acute rheumatic fever

665

Cardiac tamponade in Hashimotoʹs disease

666

Cardiac tamponade in hereditary hemorrhagic telangiectasia

667

Cardiac Tamponade in Patients with COVID-19 Infection; A Case Report

668

Cardiac tamponade in the “new device” era: Evaluation of 6999 consecutive percutaneous coronary interventions

669

Cardiac tamponade in the fibrinolytic era: Analysis of >100 000 patients with ST-segment elevation myocardial infarction

670

CARDIAC TAMPONADE SECONDARY TO CARDIOPULMONARY RESUSCITATION IN APATIENT RECEIVING ANTIPLATELET THERAPY

671

Cardiac tamponade without pericardial effusion after blunt chest trauma

672

Cardiac Tamponade: A Rare Presentation of Childhood Hypothyroidism

673

Cardiac Tamponade; A rare Presentation of Childhood Hypothyroidism

674

Cardiac teratogenicity of trichloroethylene metabolites

675

Cardiac thromboemboli complicating a stab wound to the heart

676

Cardiac tissue engineering: characteristics of in unison contracting two- and three-dimensional neonatal rat ventricle cell (co)-cultures

677

Cardiac toxicity in breast cancer patients: From a fractional point of view to a global assessment

678

Cardiac toxicity observed in association with high-dose cyclophosphamide-based chemotherapy for metastatic breast cancer

679

Cardiac toxicity of sunitinib

680

Cardiac toxicity of sunitinib and sorafenib in patients with metastatic renal cell carcinoma: Schmidinger M, Zielinski CC, Vogl UM, Bojic A, Bojic M, Schukro C, Ruhsam M, Hejna M, Schmidinger H, Clinical Division of Oncology, Department of Medicine I and

681

Cardiac transgenic matrix metalloproteinase-2 expression induces myxomatous valve degeneration: a potential model of mitral valve prolapse disease

682

Cardiac Transplant Following Failed Fontan or Glenn Procedures

683

Cardiac transplant rejection is associated with a decrease in the high-frequency components of the high-resolution, signal-averaged electrocardiogram

684

Cardiac transplantation after mechanical circulatory support: A Canadian perspective

685

Cardiac transplantation after the Fontan or Glenn procedure Original Research Article

686

Cardiac transplantation and simultaneous surgical repair of an aortic aneurysm

687

Cardiac Transplantation for Cardiac Sarcoidosis With Initial Diagnosis by Examination of the Left Ventricular Apical “Core” Excised for Insertion of a Left Ventricular Assist Device for Severe Chronic Heart Failure

688

Cardiac transplantation for hypertrophic cardiomyopathy associated with sengersʹ syndrome

689

Cardiac transplantation for the cardiologist not trained in transplantation

690

Cardiac Transplantation for The Iranian Journal of Cardiac Surgery Doxorubicin-induced Heart Failure after Chemotherapy of Ewing’s Sarcoma

691

Cardiac transplantation in a patient with protein S deficiency

692

Cardiac Transplantation in Adults With Aortic Valve Disease With Focus on the Bicuspid Aortic Valve

693

Cardiac Transplantation in Adults With Small Hearts

694

Cardiac Transplantation in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy

695

Cardiac Transplantation in Patients With Hypertrophic Cardiomyopathy

696

Cardiac Transplantation in Pediatric Patients: Fifteen-Year Experience of a Single Center

697

Cardiac Transplantation: The Columbia University Medical Center/New York—Presbyterian Hospital Manual

698

Cardiac Troponin After Major Vascular Surgery: The Role of Perioperative Ischemia, Preoperative Thallium Scanning, and Coronary Revascularization Original Research Article

699

Cardiac Troponin After Percutaneous Coronary Intervention and 1-Year Mortality in Non–ST-Segment Elevation Acute Coronary Syndrome Using Systematic Evaluation of Biomarker Trends

700

Cardiac Troponin and Brain Natriuretic Peptide: Prediction of Mortality Among Septic Pts

701

Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendan

702

Cardiac Troponin Elevation After Long-Distance Cycling is Associated with Oxidative Stress and Exercise Intensity: An Observational Study

703

Cardiac Troponin Elevations in Chronic Renal Failure: Prevalence and Clinical Significance

704

Cardiac troponin I

705

Cardiac troponin I and cardiac enzymes after electrophysiologic studies, ablations, and defibrillator implantations

706

Cardiac troponin I and creatine kinase-MB mass to rule out myocardial injury in hospitalized patients with renal insufficiency

707

Cardiac Troponin I and Tension Generation of Skinned Fibres in the Developing Rat Heart

708

Cardiac troponin I and the occurrence of cardiac arrhythmias in horses with experimentally induced endotoxaemia

709

Cardiac Troponin I and Troponin T: Recent Players in the Field of Myocardial Markers

710

Cardiac troponin I as predictor of major cardiac events in emergency department patients with acute chest pain

711

Cardiac troponin I as a marker for AMI

712

Cardiac troponin I as a marker for severity and prognosis of cardiac disease in dogs

713

Cardiac Troponin I as a Marker of Sepsis Severity and Mortality Prediction

714

Cardiac troponin i as a predictor of respiratory failure in children hospitalized with respiratory syncytial virus (RSV) infections: a pilot study

715

Cardiac troponin I elevation in acute pulmonary embolism is associated with right ventricular dysfunction

716

Cardiac Troponin I Elevation in Hospitalized Patients Without Acute Coronary Syndromes

717

Cardiac troponin I for accurate evaluation of cardiac status in myopathic patients

718

Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy

719

Cardiac troponin I in acute coronary ischemic syndromes. Epidemiological and clinical correlates

720

Cardiac troponin i in acute pericarditis

721

Cardiac troponin I in aortic valve disease

722

Cardiac troponin I in neonates undergoing the arterial switch operation

723

Cardiac Troponin I in Patients With Acute Lower Limb Ischemia

724

Cardiac Troponin I Levels Are Normal or Minimally Elevated After Transthoracic Cardioversion

725

Cardiac Troponin I Levels Measured With a High-Sensitive Assay Increase Over Time and Are Strong Predictors of Mortality in an Elderly Population

726

Cardiac troponin I mutations in Australian families with hypertrophic cardiomyopathy: clinical, genetic and functional consequences

727

Cardiac troponin I predicts myocardial dysfunction and adverse outcome in septic shock

728

Cardiac troponin I predicts myocardial dysfunction in aneurysmal subarachnoid hemorrhage

729

Cardiac troponin I proves less accurate in low-risk cardiac patients

730

Cardiac Troponin I Release After Coronary Artery Bypass Grafting Operation: Effects on Operative and Midterm Survival

731

Cardiac troponin I release after open heart surgery: a marker of myocardial protection?

732

Cardiac troponin I release in acute pulmonary embolism in relation to the duration of symptoms

733

Cardiac troponin I release in heart transplantation

734

Cardiac troponin I release in non-ischemic reversible myocardial injury from acute diphtheric myocarditis

735

Cardiac troponin I release in non-ischemic reversible myocardial injury from parvovirus B19 myocarditis

736

Cardiac troponin I: A potential marker of exercise intolerance in patients with moderate heart failure

737

Cardiac Troponin Increases Among Runners in the Boston Marathon

738

Cardiac Troponin Levels Following Complicated and Uncomplicated Epileptic Seizures

739

Cardiac troponin release in response to transient ST segment depression

740

Cardiac Troponin T (cTnT) in Hemodialysis Patients with Asymptomatic and Symptomatic Atherosclerosis

741

Cardiac troponin T and I and creatine kinase-MB as markers of myocardial injury and predictors of outcome following percutaneous coronary intervention

742

Cardiac troponin T and I, electrocardiographic wall motion analyses, and ejection fractions in athletes participating in the Hawaii Ironman Triathlon

743

Cardiac troponin T and myocardial injury during routine cardiac catheterisation in children

744

Cardiac troponin T as a marker for myocardial ischemia in patients seen at the emergency department for acute chest pain, ,

745

Cardiac Troponin T at 96 Hours After Acute Myocardial Infarction Correlates With Infarct Size and Cardiac Function Original Research Article

746

Cardiac troponin T concentration after coronary balloon angioplasty

747

Cardiac troponin T elevation after coronary artery bypass grafting is associated with increased one-year mortality

748

Cardiac troponin T in chest pain unit patients without ischemic electrocardiographic changes: angiographic correlates and long-term clinical outcomes

749

Cardiac Troponin T in Patients With Clinically Suspected Myocarditis

750

Cardiac troponin T levels are associated with poor short- and long-term prognosis in patients with acute cardiogenic pulmonary edema

751

Cardiac Troponin T Levels for Risk Stratification in Pediatric Open Heart Surgery

752

Cardiac troponin T levels in umbilical cord blood,

753

Cardiac Troponin T Levels of Umbilical Cord in Neonates with Abnormal Fetal Heart Rate

754

Cardiac troponin T mutation R141W found in dilated cardiomyopathy stabilizes the troponin T–tropomyosin interaction and causes a Ca2+ desensitization

755

Cardiac Troponin T Release Is Stimulated by Endurance Exercise in Healthy Humans

756

Cardiac troponin T, creatine kinase, and its isoform release after successful percutaneous transluminal coronary angioplasty with or without stenting, ,

757

Cardiac Troponin: A Villain or a Decent Actor in the Process of Ongoing Myocardial Injury?

758

Cardiac troponin-I content of skeletal muscle in patients with renal failure

759

Cardiac troponins after a downhill marathon

760

Cardiac troponins and oxidative stress markers in non-pregnant, pregnant and preeclampsia women

761

Cardiac troponins I and T in hemodialysis patients without acute coronary syndrome

762

Cardiac troponins in congestive heart failure, ,

763

Cardiac Troponins in Patients With Chronic Kidney Disease and Kidney Transplant Recipients Without Acute Cardiac Symptoms

764

Cardiac troponins in renal insufficiency: Review and clinical implications

765

Cardiac Troponins in Young Marathon Runners

766

Cardiac Troponins: A Tool for a Personalized Medicine Strategy in Stable Coronary Artery Disease?

767

Cardiac troponins: IT upgrade for the heart

768

Cardiac tuberculoma presenting as thrombotic thrombocytopenic purpura-hemolytic uremic syndrome

769

Cardiac tuberculosis presenting as small intestinal gangrene

770

Cardiac tumor comprising two components including typical myxoma and atypical hypercellularity suggesting a malignant change

771

Cardiac tumor due to Erdheim-Chester disease

772

Cardiac Tumor-Like Mass in a Patient With Systemic Vasculitis

773

Cardiac Tumors and Associated Arrhythmias in Pediatric Patients, With Observations on Surgical Therapy for Ventricular Tachycardia

774

Cardiac Unloading Alters Contractility and Calcium Homeostasis in Ventricular Myocytes

775

Cardiac Uptake of Minocycline and Mechanisms for In Vivo Cardioprotection Original Research Article

776

Cardiac Uses of Phosphodiesterase-5 Inhibitors

777

Cardiac vagal activity: a target for intervention in heart disease

778

Cardiac vagal control and dynamic responses to psychological stress among patients with coronary artery disease

779

Cardiac vagal control in the severity and course of depression: The importance of symptomatic heterogeneity

780

Cardiac vagal responsiveness during development in spontaneously hypertensive rats

781

Cardiac valve evaluation and adipokine levels in obese women treated with sibutramine

782

Cardiac Valve Granulocytic Sarcoma Infiltration as an Complicating Acute Myelogenous Leukemia: a Case Report

783

Cardiac valve interstitial cells secrete fibronectin and form fibrillar adhesions in response to injury

784

Cardiac Valve Interstitial Cells: Regulator of Valve Structure and Function

785

Cardiac valve involvement in systemic lupus erythematosus and primary antiphospholipid syndrome: lack of correlation with antiphospholipid antibodies

786

Cardiac Valve Prostheses at Autopsy: An Analysis of 337 Cases with Clinicopathologic Correlation

787

Cardiac valve replacement in human immunodeficiency virus–infected patients

788

Cardiac valve replacement in patients on dialysis

789

Cardiac valve replacement in patients on dialysis: influence of prosthesis on survival

790

Cardiac valves and valvular pathology: Update on function, disease, repair, and replacement

791

Cardiac Valvular Calcification in Hemodialysis Patients

792

Cardiac valvular vegetations in cancer patients: A prospective echocardiographic study of 200 patients

793

Cardiac Variables as Main Predictors of Endotracheal Reintubation Rate after Cardiac Surgery

794

Cardiac Varix in Relation to Right Atrial Free Wall Presenting as a Mass Compressing the Right Atrium and Mimicking a Pericardial Cyst

795

Cardiac Ventricular Diastolic and Systolic Duration in Children With Heart Failure Secondary to Idiopathic Dilated Cardiomyopathy

796

Cardiac versus noncardiac limits to exercise after heart transplantation, , ,

797

Cardiac Wegener’s granulomatosis masquerading as left atrial myxoma

798

Cardiac Whipple’s disease without digestive symptoms

799

Cardiac Xenotransplantation

800

Cardiac xenotransplantation: clinical experience and future direction

801

Cardiac, pancreatic, and liver abnormalities in a patient with coxsackie-B infection

802

Cardiac-directed expression of adenylyl cyclase reverses electrical remodeling in cardiomyopathy

803

Cardiac-Directed Expression of Adenylyl Cyclase VI Facilitates Atrioventricular Nodal Conduction Original Research Article

804

Cardiac-induced physiologic noise in tissue is a direct observation of cardiac-induced fluctuations

805

Cardiac-specific Abrogation of NF- κ B Activation in Mice by Transdominant Expression of a Mutant Iκ B α

806

Cardiac-specific and ligand-inducible target gene expression in transgenic mice

807

Cardiac-Specific Deletion of SOCS-3 Prevents Development of Left Ventricular Remodeling After Acute Myocardial Infarction

808

Cardiac-specific Gene Expression: a HANDful of Factors

809

Cardiac-specific haploinsufficiency of β-catenin attenuates cardiac hypertrophy but enhances fetal gene expression in response to aortic constriction

810

Cardiac-specific Overexpression of Calsequestrin Results in Left Ventricular Hypertrophy, Depressed Force–frequency Relation and Pulsus Alternans In Vivo

811

Cardiac-specific overexpression of catalase rescues ventricular myocytes from ethanol-induced cardiac contractile defect

812

Cardiac-specific overexpression of Gαq alters excitation–contraction coupling in isolated cardiac myocytes

813

Cardiac-specific overexpression of NCX1.1 mutant induces dilated cardiomyopathy in mice

814

Cardiac-specific Overexpression ofα1BAR RegulatesβAR Activity Via Molecular Crosstalk

815

Cardiac-synchronized gadolinium-enhanced MR angiography: preliminary experience for the evaluation of the thoracic aorta

816

Cardiac-triggered and segmented two-dimensional mr angiography of peripheral arterial occlusive disease: A pictorial essay

817

Cardiacα-adrenergic Receptor Expression is Regulated by Thyroid Hormone During a Critical Developmental Period

818

CARDINAL ARITHMETIC IN THE STYLE OF BARON VON MU¨ NCHHAUSEN

819

Cardinal B-spline dictionaries on a compact interval

820

Cardinal characteristics and projective wellorders

821

Cardinal Characteristics and the Product of Countably Many Infinite Cyclic Groups Original Research Article

822

Cardinal Characteristics and the Product of Countably Many Infinite Cyclic Groups Original Research Article

823

Cardinal characteristics for Menger-bounded subgroups

824

Cardinal directions between spatial objects: the pairwise-consistency problem

825

Cardinal Exponential Splines: Part II—Think Analog, Act Digital.

826

Cardinal Exponential Splines: Part I—Theory and Filtering Algorithms.

827

Cardinal functions of Pixley–Roy hyperspaces

828

Cardinal Interpolating Multiresolutions Original Research Article

829

Cardinal interpolation with polysplines on annuli Original Research Article

830

Cardinal invariants about shrinkability of unbounded sets

831

Cardinal invariants above the continuum Original Research Article

832

Cardinal invariants and -factorizability in paratopological groups

833

Cardinal invariants and independence results in the poset of precompact group topologies Original Research Article

834

Cardinal invariants in locally -minimal paratopological groups

835

Cardinal invariants of monotonically normal spaces

836

Cardinal invariants of the continuum and combinatorics on uncountable cardinals

837

Cardinal invariants related to permutation groups

838

Cardinal limits: Evidence from language awareness and bilingualism for developing concepts of number

839

Cardinal numbers associated with dense pseudocompact, countably compact, and ω-bounded subgroups

840

Cardinal sequences

841

Cardinal sequences of LCS spaces under GCH

842

Cardinal Series Interpolation to Nonuniform Grids Original Research Article

843

Cardinal temperatures for germination of Kochia scoparia (L.)

844

Cardinal transfer properties in extender models

845

Cardinal vein isomerism: An embryological hypothesis to explain a persistent left superior vena cava draining into the roof of the left atrium in the absence of coronary sinus and atrial septal defect

846

Cardinalities in depth: a formal approach to partial validation of conceptual schema

847

Cardinalities of ccc-spaces with regular -diagonals

848

Cardinalities of k-distance sets in Minkowski spaces Original Research Article

849

Cardinalities of some Lindelöf and ω1-Lindelöf T1/T2-spaces

850

Cardinality and the borda score

851

Cardinality Approach to Fuzzy Number Arithmetic

852

Cardinality bounds for subdirectly irreducible algebras Original Research Article

853

Cardinality concepts for type-two fuzzy sets

854

Cardinality constrained Boolean quadratic polytope Original Research Article

855

Cardinality constrained minimum cut problems: complexity and algorithms Original Research Article

856

Cardinality, quantifiers, and the aggregation of fuzzy criteria

857

Cardinality-restricted chains and antichains in partially ordered sets Original Research Article

858

Cardio Navigation: Planning, Simulation, and Augmented Reality in Robotic Assisted Endoscopic Bypass Grafting

859

Cardio protective effect of Coriandrum sativum L. on isoproterenol induced myocardial necrosis in rats

860

Cardioactive steroid poisoning from an herbal cleansing preparation

861

Cardioameliorative effect of punicalagin against streptozotocin-induced apoptosis, redox imbalance, metabolic changes and inflammation

862

Cardio-ankle vascular index may be an important marker of silnt neuronal injury after percutaneous coronary angiography and intervention: a prospective observational study on diagnostic accuracy

863

Cardiobacterium hominis endocarditis presenting as acute embolic stroke: A case report and review of the literature

864

Cardiocerebral Resuscitation for Cardiac Arrest

865

Cardiocerebral Resuscitation Improves Survival of Patients with Out-of-Hospital Cardiac Arrest

866

Cardiocerebral Resuscitation: A Broader Perspective

867

Cardiocerebral resuscitation: advances in cardiac arrest resuscitation

868

Cardio-cerebrovascular complications in elderly with diabetes

869

Cardio-Cerebrovascular Protective Effects of Valsartan in High-Risk Hypertensive Patients With Coronary Artery Disease (from the Kyoto Heart Study)

870

Cardiocyte cytoskeleton in patients with left ventricular pressure overload hypertrophy

871

Cardiodepressant Effects of Interferon-γand Endotoxin Reversed by Inhibition of NO Synthase 2 in Rat Myocardium

872

Cardiodepressive Mediators Are Released After Ischemi From an Isolated Heart: Role of Coronary Endothelial Cells

873

Cardioembolic Source of ST-Segment Elevation Myocardial Infarction

874

Cardioembolic Stroke

875

Cardioembolic stroke: an update

876

Cardioesophageal reflex: mechanism for “linked angina” in patients with angiographically proven coronary artery disease

877

Cardio-facio-cutaneous syndrome and moyamoya syndrome

878

Cardiogel as an Instructive Microenvironment for in vitro Differentiation of Bone Marrow Derived Mesenchymal Stem Cells into Cardiomyocytes

879

Cardiogenic and Aortogenic Brain Embolism Review Article

880

Cardiogenic shock

881

Cardiogenic shock

882

Cardiogenic Shock and Anterior Papillary Muscle Rupture Caused by Blood Supply to Diagonal Artery

883

cardiogenic shock and anterior papillary muscle rupture caused by blood supply to diagonal artery

884

Cardiogenic shock at admission in patients with multivessel disease and acute myocardial infarction treated with percutaneous coronary intervention: Related factors

885

Cardiogenic shock caused by right ventricular infarction: A report from the SHOCK registry

886

Cardiogenic shock caused by simultaneous subacute stent thrombosis after implantation of sirolimus-eluting stents

887

Cardiogenic shock complicating acute carbon monoxide poisoning despite neurologic and metabolic recovery

888

Cardiogenic shock complicating acute coronary syndromes

889

Cardiogenic shock complicating acute myocardial infarction in California: effect of invasive procedures on mortality

890

Cardiogenic shock complicating acute myocardial infarction in elderly patients: Does admission to a tertiary center improve survival?

891

Cardiogenic shock complicating acute myocardial infarction: Predictors of death

892

Cardiogenic shock complicating acute myocardial infarction—etiologies, management and outcome: a report from the SHOCK Trial Registry

893

Cardiogenic shock due to acute severe mitral regurgitation complicating acute myocardial infarction: a report from the SHOCK Trial Registry

894

Cardiogenic shock due to cardiac free-wall rupture or tamponade after acute myocardial infarction: a report from the SHOCK Trial Registry

895

Cardiogenic shock due to coronary narrowings one day after a MAZE III procedure

896

Cardiogenic shock due to myocardial infarction caused by coronary vasospasm associated with hyperthyroidism

897

Cardiogenic Shock due to Psychosis-Induced Inverted Takotsubo Cardiomyopathy Bridged-to-Recovery with a Percutaneous Left Ventricular Assist Device

898

Cardiogenic shock following electro-cardioversion of new onset atrial flutter

899

Cardiogenic Shock in a Hemodialyzed Patient on Flecainide: Treatment with Intravenous Fat Emulsion, Extracorporeal Cardiac Life Support, and CytoSorb® Hemoadsorption

900

CARDIOGENIC SHOCK IN ADULT PATIENTS WITH NON-ST ELEVATION MYOCARDIAL INFARCTION

901

Cardiogenic shock with non-ST-segment elevation myocardial infarction: a report from the SHOCK Trial Registry

902

Cardiogenic Shock Without Flow-Limiting Angiographic Coronary Artery Disease—(from the Should We Emergently Revascularize Occluded Coronary Arteries for Cardiogenic Shock Trial and Registry)

903

Cardiogenic shock: Basics and clinical considerations

904

Cardiogenic Shock: Collaboration Between Cardiac Surgery and Cardiology Subspecialties to Bridge to Recovery

905

Cardiogenic shock: is there light at the end of the tunnel?

906

Cardiographic conundrum: Adding insult to injury

907

Cardiohepatic Interactions in Heart Failure: An Overview and Clinical Implications

908

Cardioinhibitory syncope due to bloodphobia associated asystole

909

Cardiolinka bohemica (Barrande, 1881) – A first representative of the Late Silurian Bohemian type Bivalvia fauna from the northern Arabian Plate, Southeast Turkey

910

Cardiolipin Clusters and Membrane Domain Formation Induced by Mitochondrial Proteins

911

Cardiolipin deficiency leads to decreased cardiolipin peroxidation and increased resistance of cells to apoptosis

912

Cardiolipin Enhances Protein C Pathway Anticoagulant Activity,

913

Cardiologic and neurologic findings in left ventricular hypertrabeculation/noncompaction relating to echocardiographic indication

914

Cardiological applications of nuclear medicine Review Article

915

Cardiological assessment of first-degree relatives in sudden arrhythmic death syndrome

916

Cardiologist Concordance With the American College of Cardiology Appropriate Use Criteria for Cardiac Testing in Patients With Coronary Artery Disease

917

Cardiologist in the carotids

918

Cardiologist in the dugout

919

Cardiologist in the Land of the Thunder Dragon: A Medical Mission to Bhutan

920

Cardiologist on trial: reflections on credible evidence

921

Cardiologist versus internist management of patients with unstable angina: Treatment patterns and outcomes

922

Cardiologist’s Role in Improving Glucose Control and Global Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus

923

Cardiologists Knowledge and Attitudes About Methadone and Buprenorphine Maintenance Treatment: A Survey Study in Tehran, Iran

924

Cardiologistsʹ discussions about sexuality with patients with chronic coronary artery disease

925

Cardiologists in casualty?

926

Cardiologistsʹ knowledge of the 2005 American Heart Association Resuscitation Guidelines: The Athens Study

927

Cardiologistsʹ practices compared with practice guidelines: Use of beta-blockade after acute myocardial infarction

928

Cardiologists recommend Fragmin

929

Cardiologists versus internists in the care of unstable angin

930

Cardiologists, the PINNACLE Registry, and the “Meaningful Use” of Electronic Health Records

931

Cardiologists’ Knowledge and Perception towards American Heart Association Guidelines of Cardiopulmonary Resuscitation; a Letter to Editor

932

Cardiologists’ Perception of Risk of Coronary Revascularization Procedures

933

Cardiology 2010, 13th Annual Update on Pediatric Cardiovascular Disease: Abstracts

934

Cardiology and emergency medicine: United We Stand, divided we fall

935

Cardiology and neurologic family screening in noncompaction

936

Cardiology and the Critical Care Crisis: A Perspective Review Article

937

Cardiology in a Flat World

938

Cardiology in cattle: Knowledge and expertise are the sine qua non for optimal economic medicine

939

Cardiology in contemporary China: An update

940

Cardiology in India

941

Cardiology in India: State of the Art or Straight off the Heart?

942

Cardiology in South America

943

Cardiology Integration: Challenge and Opportunity

944

Cardiology management improves secondary prevention measures among patients with coronary artery disease Original Research Article

945

Cardiology participation improves outcomes in patients with new-onset heart failure in the outpatient setting

946

Cardiology rounds

947

Cardiology screening on the net

948

Cardiology Workforce Crisis: Shortage or Surplus?

949

Cardiology Workforce Revisited

950

Cardiology workforce: there’s already a shortage, and it’s getting worse!

951

Cardiology, for what itʹs worth

952

Cardiology: “Itʹs small world after all”

953

Cardiology: a call for papers

954

Cardiology: American Journal of Medicine theme issue

955

Cardiology: call for papers

956

Cardiology: the past, the present, and the future

957

Cardiology: where to go from here?

958

Cardiomegaly as a possible cause of lung dysfunction in patients with heart failure

959

Cardiomegaly in a young infant

960

Cardiometabolic Abnormalities in Current National Football League Players

961

Cardiometabolic Consequences of Gestational Dysglycemia

962

Cardiometabolic Risk and Cognitive Function Decline in U.S. Elderly

963

Cardiometabolic Risk Factors in Fructose-Induced Insulin Resistant Rats: Comparative Effects of Palm and Olive Oils

964

Cardio-metabolic risk factors in Iranian children: where we are and the others?

965

Cardiometabolic risk factors in polycystic ovary syndrome

966

Cardiomodulating Activity of Gongronema latifolium and Lisinopril in Doxorubicin-induced Cardiotoxicity in Wistar Rats

967

Cardiomyocyte Apoptosis After Antegrade and Retrograde Cardioplegia

968

Cardiomyocyte apoptosis and ischemic preconditioning in open heart operations

969

Cardiomyocyte apoptosis in cocaine-induced myocarditis with involvement of bundle of His and left bundle branch

970

Cardiomyocyte apoptosis in experimental coxsackievirus B3 myocarditis

971

Cardiomyocyte death and renewal in the normal and diseased heart

972

Cardiomyocyte Grafting for Cardiac Repair: Graft Cell Death and Anti-Death Strategies

973

Cardiomyocyte Hypertrophy, Oncosis, and Autophagic Vacuolization Predict Mortality in Idiopathic Dilated Cardiomyopathy With Advanced Heart Failure

974

Cardiomyocyte Injury Assessed by a Highly Sensitive Troponin Assay and Sudden Cardiac Death in the Community: The Cardiovascular Health Study

975

Cardiomyocyte Marker Expression in Mouse Embryonic Fibroblasts by Cell-Free Cardiomyocyte Extract and Epigenetic Manipulation

976

Cardiomyocyte Mitochondrial Dynamics in Health and Disease and the Role of Exercise Training: A Brief Review

977

Cardiomyocyte proteome 2-D gel database construction: Detection and identification of co-migrating proteins

978

Cardiomyocyte Resistance to Doxorubicin Mediated by A3 Adenosine Receptor

979

Cardiomyocyte resistance to doxorubicin toxicity may be achieved by adenosine signaling

980

Cardiomyocyte transplantation does not reverse cardiac remodeling in rats with chronic myocardial infarction

981

Cardiomyocyte Transplantation Improves Heart Function

982

Cardiomyocyte-restricted deletion of connexin43 during mouse development

983

Cardiomyocytes from hearts with left ventricular dysfunction after ischemia-reperfusion do not manifest contractile abnormalities

984

Cardiomyocytes morphologic and metabolic response to angiotensin II is mediated by NFκB-induced inactivation of PPAR isoforms

985

Cardiomyocytes purified from differentiated embryonic stem cells exhibit characteristics of early chamber myocardium

986

Cardiomyocytes β-adrenergic receptors are resistants to short-term desensitization

987

Cardiomyocyte-Specific Deletion of Gsk3α Mitigates Post–Myocardial Infarction Remodeling, Contractile Dysfunction, and Heart Failure

988

Cardiomyocyte-specific desmin rescue of desmin null cardiomyopathy excludes vascular involvement

989

Cardiomyocyte-targeted siRNA delivery by prostaglandin E2-Fas siRNA polyplexes formulated with reducible poly(amido amine) for preventing cardiomyocyte apoptosis

990

Cardiomyogenic potential of skeletal muscle-derived progenitor cells

991

Cardiomyogenic stem and progenitor cell plasticity and the dissection of cardiopoiesis

992

Cardiomyopathic lentiginosis: an echo-Doppler report

993

Cardiomyopathies: from genetics to the prospect of treatment

994

CARDIOMYOPATHIES: PRESENTATION AND COMPLICATIONS IN CHILDREN AT DERA ISMAIL KHAN

995

Cardiomyopathy and Myopathy in Left Ventricular Noncompaction

996

Cardiomyopathy Due to Nonsustained Ventricular Tachycardia Originating from the Aortic Sinus Cusp

997

Cardiomyopathy in a Male with Cystinosis

998

Cardiomyopathy in childhood, mitochondrial dysfunction, and the role of L-carnitine

999

Cardiomyopathy in Danish patients with coeliac disease

1000

Cardiomyopathy in infancy and postmortem di diagnosis of a fatty acid oxidation defect

بازگشت